Skip to content
OpenCapital
Get started

Globus Medical GMED Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

Abbott logo
AbbottABT
$1M-97.4%
Baxter International logo
Baxter InternationalBAX
——
HEICO logo
HEICOHEI
——

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's contingent consideration liability (non-current)?
Globus Medical (GMED) reported contingent consideration liability (non-current) of $100.32M in Q1 2026.
How has Globus Medical's contingent consideration liability (non-current) changed year-over-year?
Globus Medical's contingent consideration liability (non-current) decreased by 15.0% year-over-year, from $118.06M to $100.32M.
What is the long-term trend for Globus Medical's contingent consideration liability (non-current)?
Over 5 years (2020 to 2025), Globus Medical's contingent consideration liability (non-current) has grown at a 22.2% compound annual growth rate (CAGR), from $37.27M to $101.51M.